NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹17 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -2.92 | |
| Mar2024 | ₹46 Cr | 13.13 | |
| Mar2023 | ₹41 Cr | 98.30 | |
| Mar2022 | ₹20 Cr | 18.59 | |
| Mar2021 | ₹17 Cr | - | |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹19,152.4 Cr | -6.9% | -10% | 9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -6.9% |
-10% |
9.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses